Figure 5. Dynamics of anti-heart antibodies and the frequency of atrial fibrillation during therapy. Left - titers IgG to anti-myocardial tissue (MT), anti-cardiomyocytes (CMC), anti-smooth muscle (SM), anti-endothelial cells (E), anti-conducting system (CS) antibodies and specific anti-nuclear antibodies (ANA), measured as multiplies of normal; * significance of differences compared with baseline value with p <0.05, ** - p <0.01. Right - frequency of AF paroxysms during complex treatment (estimates after 6 months from the start of basic therapy).